Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06291922 · ClinicalTrials.gov registry record · NA
Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation
A NA study of Heart Failure, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 4
- Study locations
NCT06291922: Recruiting NA study of Heart Failure, sponsored by University of Pennsylvania.
NCT06291922 is a NA study of Heart Failure that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06291922, a NA study of Heart Failure, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers will compare the effects of an exercise intervention vs. usual care on physical activity and capacity, frailty and muscle mass, and quality of life.
Primary Outcome
The investigators will compare the effects of the exercise intervention vs. usual care on physical activity and capacity measured by daily steps captured by an activity tracking watch.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Exercise Intervention
Study Locations (4)
Michigan
- Henry Ford Health - Detroit
Ohio
- Cleveland Clinic Foundation - Cleveland
Pennsylvania
- University of Pennsylvania - Philadelphia
Utah
- University of Utah Health - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT06291922 shows while recruiting
NCT06291922 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT06291922 reports a single indexed study location in Michigan, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06291922 about?
NCT06291922 is a clinical study titled "Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation". The goal of this clinical trial is to evaluate the effects of a home-based exercise program using mobile technology on physical activity and capacity, frailty and muscle mass, and quality of life in patients with a newly implanted HeartMate 3 left ventricular assist device (HM3 LVAD). Researchers wi...
What is the current status of trial NCT06291922?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-14. Estimated completion is 2028-06-30.
What conditions does trial NCT06291922 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT06291922?
The interventions under investigation include: Usual Care (BEHAVIORAL), Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06291922?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06291922 being conducted?
This trial has 4 study locations across Michigan, Ohio, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06291922's enrollment target sits among peer trials
100 212th of 397 higher than 177 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI